Highmark Commercial Medical Policy in West Virginia

Section: Durable Medical Equipment
Number: E-45
Topic: Interferential Stimulator
Effective Date: July 25, 2011
Issued Date: July 25, 2011
Date Last Reviewed: 12/2010

General Policy Guidelines

Indications and Limitations of Coverage

Interferential stimulation is experimental/investigational. Review of available literature reveals a lack of controlled clinical trials that prove the effectiveness of the procedure. As such, interferential stimulator devices and any related supplies (e.g., electrodes [A4556], lead wires [A4557]) used in the home and clinical setting are not covered. A participating, preferred, or network provider can bill the member for the denied service.

For additional information, see Medical Policy Bulletin Y-1.

Description

Interferential stimulation is a type of electrical nerve stimulation that uses paired electrodes of two independent circuits carrying medium-frequency alternating currents. The electrodes are aligned on the skin so that the current flowing between each pair intersects at the underlying target. This maximizes the current permeating the tissues while minimizing unwanted stimulation of cutaneous nerves.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

A4556A4557E1399   

Traditional Guidelines

Refer to General Policy Guidelines

FEP Guidelines

This medical policy may not apply to FEP. Medical policy is not an authorization, certification, explanation of benefits, or a contract. Benefits are determined by the Federal Employee Program.

PPO Guidelines

Refer to General Policy Guidelines

Managed Care POS Guidelines

Refer to General Policy Guidelines

Publications

Provider News

02/2011, Blue Shield to stop covering interferential stimulator
08/2011, Supplies used with interferential stimulator considered not covered

References

The effects of home interferential therapy on post-operative pain, edema, and range of motion of the knee, Jarit GJ, Clin J Sport Med, 01-JAN-2003; 13(1): 16-20

Zambito A, et al. Interferential and horizontal therapies in chronic low back pain due to multiple vertebral fractures: a randomized, double blind, clinical study. Osteoporos Int. 2007 Nov;18(11):1541-5. Epub 2007 Jul 4.

Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147:478-91.

Poitras S, Brosseau L. Evidence-informed management of chronic low back pain with transcutaneous electrical nerve stimulation, interferential current, electrical muscle stimulation, ultrasound, and thermotherapy. Spine J. 2008;8(1):226-33.

Rutjes AWS, Nüesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, Brosseau L, Reichenbach S, Jüni P. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No:CD002823. DOI:10.1002/14651858. CD002823. pub2.

Fuentes JP, Armijo Olivo S, Magee DJ, et al. Effectiveness of interferential current therapy in the management of musculoskeletal pain: A systematic review and meta-analysis. Phys Ther. 2010;90(9):1219-38.

View Previous Versions

[Version 005 of E-45]
[Version 004 of E-45]
[Version 003 of E-45]
[Version 002 of E-45]
[Version 001 of E-45]

Table Attachment

Text Attachment

Procedure Code Attachments

Diagnosis Codes

Glossary





This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Highmark West Virginia plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Highmark West Virginia retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark West Virginia. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.